Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Transplantation in Patients With Myelodysplastic Syndrome Based on Risk According to Revised-International Prognostic Scoring System (R-IPSS)

NCT04801563 is registered in ClinicalTrials.gov with University Of Perugia as lead sponsor.

NCT NCT04801563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04801563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Transplantation in Patients With Myelodysplastic Syndrome Based on Risk According to Revised-International Prognostic Scoring System (R-IPSS)
Lead sponsor
University Of Perugia
Phase
Not applicable
Overall status
Unknown status
Start date
September 20, 2019
Completion date
September 19, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mds and allogeneic stem cell transplantation